Antibody Market Insights Dataset Release: Supplier Share
5
Min Read
In this blog:
- Three key takeaways from our antibody supplier share data
- How can you analyse market share data?
- Download data on the top ten antibody companies in 2023!
At CiteAb, we collect reagent information from the scientific literature in order to identify and understand market trends and research reagent use.
We’ve just released our latest Market Insights Datasets, focusing on Supplier Share across reagent markets!
The Market Insights Package is one of our data products comprising four structured, quantitative datasets: Top products, Countries, Research areas and Company share trends.
We currently provide Market Insight packages for research ELISA Kits, Growth Factors, Antibodies and Biochemicals, but can create them for all reagent types we collect data on.
In this blog we are focusing only on the RUO antibody company share release from the Market Insights package, a dataset covering over 295 antibody suppliers and over 2 million citations.
Read on as we share some interesting takeaways, analysis ideas and a data download!
Three research antibody market share trends
1. The top three antibody supplier have led for several years
From our Antibody Market Insight dataset we found that the top three companies have impressively remained the same once again in 2023, in spite of many other companies successfully growing their share.
These leading antibody companies, supporting many researchers with their products, were:
- Abcam – with an antibody market share of ~20%
- Cell Signaling Technology – with an antibody market share ~19%
- Thermo Fisher Scientific, with their Invitrogen Antibodies brand – antibody market share ~12%
We have previously analysed antibody supplier share over on our blog, finding that Abcam and Cell Signaling Technology have been vying for that top spot in recent years. In 2023 our data shows that their market share remains very close to call.
2. A change in the top five ranked suppliers
We also noted increasing competition in the antibody market, shown by a number of companies increasing their share of citations.
A few examples of companies with impressive growth trajectories include Invitrogen Antibodies, BioLegend and Jackson ImmunoResearch.
We have previously noted BioLegend’s impressive growth in citation share on our blog. This trajectory is only continuing, and in 2023 resulted in a rise in rank to fifth place in the antibody market.
They have replaced Santa Cruz Biotechnology in this spot, the first time the top five companies have changed in nine years.
Thermo Fisher Scientific’s brand Invitrogen Antibodies, similarly, have been edging closer to the top two market leaders year on year. Although their rank hasn’t changed in 2023, we will be interested to see if they can continue this growth moving forward and challenge the top two.
Jackson ImmunoResearch, a secondary antibody market leader, have also seen growth in the overall market.
There are many other vendors increasing their share that we haven’t been able to pick out here. If you’re interested in seeing the full list, get in touch!
3. Consistent leaders in the secondary antibody market
When we look specifically at the secondary market, the leading companies differ from the overall market. Interestingly, the top three companies in 2023 have remained consistent for the last five years. They were:
- Thermo Fisher Scientific with their Invitrogen Antibodies brand- ~40% secondary antibody market share
- Jackson ImmunoResearch – ~13% secondary antibody market share
- Abcam ~12% secondary antibody market share
You can download data on the top ten suppliers for antibodies and their citation share in 2023 for the primary and secondary market at the bottom of this blog.
Three ideas for antibody market analysis
Have these trends piqued your interest? There’s loads of really interesting analysis you can carry out with supplier share data to inform your decision making. Some of this analysis could also be applied to data you may have internally.
Here’s three ideas for your team:
1. Benchmark your performance
Delving into trends in company citations over time can help you to position yourself in the market, and spot key competitors who you may not have been aware of. You could then see how your trajectory compares over time.
2. Identify key trends
Another way you could use this data is to discover important trends. Doing so can help identify missed opportunities – should you be dedicating your sales efforts into the secondary market? How is the overall market changing – are suppliers from a certain region rising up the ranks, or those specialising in particular research areas?
3. Develop an informed company strategy
Understanding the overall market can help you to navigate a highly crowded space of around 300 vendors, by quantitatively seeing the impact of changes to your strategy on your market share.
Here’s some more ways our datasets for products, research areas and countries can be utilised across your company.
Wrap- up
If you’d like to learn more about subscribing to our research antibody market share reports, please don’t hesitate to reach out to the team here.
We also offer a Complete Market Dataset subscription, which you can get a demo for by a member of the team.
And if you’d like to explore some reagent market analysis in more depth, we have plenty more content over on our blog!
Finally, you can download a free dataset below on the top 10 antibody suppliers of 2023 and their market share below, to help with your own analysis!
- Rhys B and the CiteAb team
Sign up for data
Something seems to have gone wrong while loading the form.
Drop us a message and we can send you the data directly.
